MWNA
CDMO

Marshall Wace North America’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Marshall Wace North America’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-16,889
Closed -$195K – 1832
2020
Q4 		$195K Buy
+16,889
New +$154K ﹤0.01% 1232

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Marshall Wace North America's CDMO Position: Q1 2021 in Review

Marshall Wace North America sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2021, closing a stake of 16,889 shares — an estimated $195K sold.

Marshall Wace North America first reported a position in CDMO in Q4 2020 and held it in 1 quarter. The position peaked at $195K in Q4 2020. 158 funds tracked by Wall St. Rank hold CDMO as of Q1 2021.

  • Marshall Wace North America reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Marshall Wace North America sold 16,889 Avid Bioservices, Inc. Common Stock shares in Q1 2021, an estimated $195K.
  • Marshall Wace North America first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Marshall Wace North America's Avid Bioservices, Inc. Common Stock position peaked at $195K in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.